Adrenocortical endocrine disruption

Journal of Steroid Biochemistry and Molecular Biology

Volumn 155, Issue , 2016, Pages 199-206

  Harvey, Philip W ^a  

^a UK   (United Kingdom)

Author keywords

Adrenal cortex; Adrenal hypertrophy; Adrenal toxicity; Adrenocortical insufficiency; H295R cell line; Steroidogenesis; Stress; Toxicity

Indexed keywords

3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ALDOSTERONE; ALDOSTERONE SYNTHASE; AMINOGLUTETHIMIDE; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); CYTOCHROME P450; CYTOCHROME P450 11B1; CYTOCHROME P450 17; ENVIRONMENTAL CHEMICAL; ETOMIDATE; HYDROCORTISONE; MELANOCORTIN 2 RECEPTOR; STEROID 21 MONOOXYGENASE; UNCLASSIFIED DRUG; CORTICOSTERONE; ENDOCRINE DISRUPTOR;

ADDISON DISEASE; ADRENAL CORTEX FUNCTION; ADRENAL CORTEX INSUFFICIENCY; ADRENAL HYPERPLASIA; CONGENITAL ADRENAL HYPERPLASIA; CORTICOTROPIN TEST; ENVIRONMENTAL EXPOSURE; ENZYME INHIBITION; HUMAN; NONHUMAN; REPRODUCTIVE TOXICITY; REVIEW; SALT WASTING; STEROIDOGENESIS; STRESS; WILDLIFE; ADRENAL CORTEX; ADRENAL INSUFFICIENCY; AGONISTS; ANIMAL; BIOSYNTHESIS; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ADRENAL CORTEX; ADRENAL INSUFFICIENCY; AMINOGLUTETHIMIDE; ANIMALS; CELL LINE, TUMOR; CORTICOSTERONE; CYTOCHROME P-450 ENZYME SYSTEM; DISEASE MODELS, ANIMAL; ENDOCRINE DISRUPTORS; ETOMIDATE; GENE EXPRESSION REGULATION; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; RECEPTORS, CORTICOTROPIN; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL;

EID: 84949450170     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.10.009     Document Type: Review

References (59)

1. A. Cockburn, and K.-H. Leist Current and regulatory trends in endocrine and hormonal toxicology P.W. Harvey, K.C. Rush, A. Cockburn, Endocrine and Hormonal Toxicology 1999 Wiley Chichester 507 534
2. P.W. Harvey, and D. Everett The adrenal cortex and steroidogenesis as cellular and molecular targets for toxicity: critical omissions from regulatory endocrine disrupter screening strategies for human health J. Appl. Toxicol. 23 2003 81 87
3. P.W. Harvey, D.J. Everett, and C.J. Springall Adrenal toxicology: a strategy for assessment of functional toxicity to the adrenal cortex and steroidogenesis J. Appl. Toxicol. 27 2007 103 115
4. W.E. Ribelin The effects of drugs and chemicals upon the structure of the adrenal gland Fundam. Appl. Toxicol. 4 1984 105 119
5. P.W. Harvey, and C. Sutcliffe Adrenocortical hypertrophy: establishing cause and toxicological significance J. Appl. Toxicol. 30 2010 617 626
6. FDA, Endocrine disruption potential of drugs: nonclinical evaluation, Draft Guidance, September 2013, Federal Register 78: 183: 57859.
7. J.P. Hinson, and P.W. Raven Effects of endocrine-disrupting chemicals on adrenal function Best Pract. Res. Clin. Endocrinol. Metab. 20 2006 111 120
8. A. Hontela, and M.M. Vijayan Adrenocortical toxicology in fishes P.W. Harvey, D.J. Everett, C.J. Springall, Adrenal Toxicology 2009 Informa Healthcare New York 233 256
9. L.H. Schwake, C.R. Smith, F.I. Townsend, and et al. Health of common bottlenose dolphins (Tursiops truncatus) in Barataria Bay Louisiana, following the Deepwater Horizon oil spill Environ. Sci.Technol. 48 2014 93 103
10. P.W. Harvey The Adrenal in Toxicology: Target Organ and Modulator of Toxicity 1996 Taylor and Francis London
11. P.W. Harvey, D.J. Everett, and C.J. Springall Adrenal Toxicology 2009 Informa Healthcare New York
12. P.W. Harvey Toxic responses of the adrenal cortex C.A. McQueen, Comprehensive Toxicology vol. 11 2010 Academic Press Oxford 265 289
13. T.J. Rosol, R.A. DeLellis, P.W. Harvey, and C. Sutcliffe Endocrine system W.M. Haschek, C.G. Rousseaux, M.A. Wallig, Haschek and Rousseaux's Handbook of Toxicologic Pathology 2013 Elsevier Inc., Academic Press 2391 2492
14. J.C. Buckingham The hypothalamo-pituitary-adrenocortical axis: endocrinology, pharmacology, pathophysiology and developmental effects P.W. Harvey, D.J. Everett, C.J. Springall, Adrenal Toxicology 2009 Informa Healthcare New York 77 107
15. P.W. Harvey, D.J. Everett, and C.J. Springall Adrenal toxicology: molecular targets, endocrine mechanisms, hormonal interactions, assessment models and species differences in toxicity P.W. Harvey, D.J. Everett, C.J. Springall, Adrenal Toxicology 2009 Informa Healthcare New York 3 35
16. M. Fassnacht, F. Beuschlein, S. Vay, and et al. Aminoglutethimide suppresses adrenocorticotrophin receptor expression in the NCI-h295 adrenocortical tumor cell line J. Endocrinol. 159 1998 35 42
17. L.P. Walsh, C.N. Kuratko, and D.M. Stocco Econazole and miconazole inhibit steroidogenesis and disrupt steroidogenic acute regulatory (StAR) protein expression post-transcriptionally J. Steroid Biochem. Mol. Biol. 75 2000 229 236
18. L.P. Walsh, and D.M. Stocco Effects of lindane on steroidogenesis and steroidogenic acute regulatory protein expression Biol. Reprod. 63 2000 1024 1033
19. A. Oskarsson, E. Ulleras, K.E. Plant, and et al. Steroidogenic gene expression in H295R cells and the human adrenal gland: adrenotoxic effects of lindane in vitro J. Appl. Toxicol. 26 2006 484 492
20. S.F. Kan, M.M. Kau, L. Low-Tone Ho, and et al. Inhibitory effects of bromocriptine on corticosterone secretion in male rats Eur. J. Pharmacol. 468 2003 141 149
21. K. Hilscherova, P.D. Jones, T. Gracia, and et al. Assessment of the effects of chemicals on the expression of ten steroidogenic genes in theH295R cell line using real-time PCR Toxicol. Sci. 81 2004 78 89
22. M.K. Johansson, J.T. Sanderson, and B.O. Lund Effects of 3-MeSO2-DDE and some CYP inhibitors on glucocorticoid steroidogenesis in the H295R human adrenocortical carcinoma cell line Toxicol. In Vitro 16 2002 113 121
23. M. Hecker, H. Hollert, R. Cooper, and et al. The OECD validation program of theH295R steroidogenesis assay for the identification of in vitro inhibitors and inducers of testosterone and estradiol production. Phase 2: inter-laboratory pre-validation studies Environ. Sci. Pollut. Res. 14 Special Issue 1 2007 23 30
24. D.C. Kossor, S. Kominami, S. Takemori, and et al. Role of the steroid 17 a-hydroxylase in spironolactone-mediated destruction of adrenal cytochrome P-450 Mol. Pharmacol. 40 1991 321 325
25. L.A. Li, and P.W. Wang PCB126 induces differential changes in androgen, cortisol and aldosterone biosynthesis in human adrenocortical H295R cells Toxicol. Sci. 85 2005 530 540
26. R.F. Canton, J.T. Sanderson, S. Nijmeijer, and et al. In vitro effects of brominated flame retardents and metabolites on CYP17 catalytic activity: a novel mechanism of action Toxicol. Appl. Pharmacol. 216 2006 274 281
27. J.L. McCarthy, C.W. Reitz, and L.K. Wesson Inhibition of adrenal corticosteroidogenesis in the rat by cyanotrimethylandrostenolone, a synthetic androstane Endocrinology 79 1966 1123 1139
28. G.O. Potts, J.E. Creange, H.R. Harding, and et al. Trilostane, an orally active inhibitor of steroid biosynthesis Steroids 32 1978 257 267
29. 2-PCBs on adrenocortical steroidogenesis in H295R human adrenocortical carcinoma cells Chemosphere 63 2006 772 784
30. L. Blaha, K. Hilscherova, E. Mazurova, and et al. Alteration of steroidogenesis in H295R cells by organic sediment contaminants and relationships to other endocrine disrupting effects Environ. Int. 32 2006 749 757
31. L. Ding, M.B. Murphy, Y. He, and et al. Effects of brominated flame retardants and brominated dioxins on steroidogenesis in H295R human adrenocortical carcinoma cell line Environ. Toxicol. Chem. 26 2007 764 772
32. P. Kempna, G. Hofer, P.E. Mullis, and et al. Pioglitazone inhibits androgen production in NCIH295R cells by regulating gene expression of CYP17 and HSD3 B2 Mol. Pharmacol. 71 2007 787 798
33. B.D. Albertson, R.B. Hill, K.A. Sprague, and et al. Effects of the antiglucocorticoid RU486 on adrenal steroidogenic enzyme activity and steroidogenesis Eur. J. Endocrinol. 130 1994 195 200
34. S. Ohno, S. Shinoda, S. Toyoshima, and et al. Effects of flavonoid phytochemicals on cortisol production and on activities of steroidogenic enzymes in human adrenocortical H295R cells J. Steroid Biochem. Mol. Biol. 80 2002 355 363
35. G.W. Liddle, D.P. Island, E.M. Lance, and et al. Alterations in adrenal steroid patterns in man resulting from treatment with a chemical inhibitor of 11β-hydroxylase J. Clin. Endocrinol. 18 1958 906 912
36. P.J. Hornsby Steroid and xenobiotic effects on the adrenal cortex: mediation by oxidation and other mechanisms Free Radic. Biol. Med. 6 1989 103 115
37. O. Lindhe, B. Skoseid, and I. Brandt Cytochrome P450-catalysed binding of 3-methylsulfonyl-DDE and o,p-DDD in human adrenal zona fasciculata/reticularis J. Clin. Endocrinol. Metab. 87 2002 1319 1326
38. I.M. Leddingham, and I. Watt Influence of sedation on mortality in multiple trauma patients Lancet 1 1983 1270
39. P.W. Raven, and J.P. Hinson Transport, actions and metabolism of adrenal hormones and pathology and pharmacology of the adrenal gland P.W. Harvey, The Adrenal in Toxicology: Target Organ and Modulator of Toxicity 1996 Taylor & Francis London 53 79
40. K. Imagawa, S. Okayama, M. Takaoka, and et al. Inhibitory effect of efonidipine on aldosterone synthesis and secretion in human adrenocarcinoma (H295R) cells J. Cardiovasc. Pharmacol. 47 2006 133 138
41. H.R. Andersen, A.M. Vingaard, T.H. Rasmusse, and et al. Effects of currently used pesticides in assays for estrogenicity and aromatase activity in vitro Toxicol. Appl. Pharmacol. 179 2000 1 12
42. J.T. Sanderson, R.J. Letcher, M. Heneweer, and et al. Effects of chloro-s-triazine herbicides and metabolites on aromatase activity in various human cell lines and on vitellogenin production in male carp hepatocytes Environ. Health Perspect. 109 2001 1027 1031
43. J.T. Sanderson, J. Boerma, G.W. Lansbergen, and et al. Induction and inhibition of aromatase (CYP19) activity by various classes of pesticides in H295R human adrenocortical carcinoma cells Toxicol. Appl. Pharmacol. 82 2002 44 54
44. U. Muller-Vieira, M. Angotti, and R.W. Hartman The adrenocortical tumor cell line NCI-H295R as an in vitro screening system for the evaluation of CYP11 B2 (aldosterone synthase) and CYP11B1 (steroid-11beta-hydroxylase) inhibitors J. Steroid Biochem. Mol. Biol. 96 2005 259 270
45. T. Gracia, K. Hilscherova, P.D. Jones, and et al. Modulation of steroidogenic gene expression and hormone production of H295R cells by pharmaceuticals and other environmentally active compounds Toxicol. Appl. Pharmacol. 225 2007 142 153
46. J.B. Lundy, M.L. Slane, and J.D. Frizzi Acute adrenal insufficiency after a single dose of etomidate J. Intensive Care Med. 22 2007 111 117
47. S.F. Akana, J. Shinsako, and M.F. Dallman Drug-induced adrenal hypertrophy provides evidence for reset in the adrenocortical system Endocrinology 113 1983 2232 2237
48. J. Pudney, G.M. Price, B.J. Whitehouse, and G.P. Vinson Effects of chronic ACTH stimulation on the morphology of the rat adrenal cortex Anat. Rec. 210 1984 603 615
49. R. Baos, and J. Blas Adrenal toxicology in birds: environmental contaminants and the avian response to stress P.W. Harvey, D.J. Everett, C.J. Springall, Adrenal Toxicology 2009 Informa Healthcare New York 257 293
50. T. Sanderson Adrenocortical toxicology in vitro: assessment of steroidogenic enzyme expression and steroid production in H295R cells P.W. Harvey, D.J. Everett, C.J. Springall, Adrenal Toxicology 2009 Informa Healthcare New York 175 182
51. J. Parmar, and W. Rainey Comparisons of adrenocortical cell lines as in vitro test systems P.W. Harvey, D.J. Everett, C.J. Springall, Adrenal Toxicology 2009 Informa Healthcare New York 183 204
52. J.C.W. Rijk, A.A.C.M. Peijnenburg, M.H. Blokland, A. Lommen, L.A.P. Hoogenboom, and T.F.H. Bovee Screening for modulatory effects on steroidogenesis using the human H295R adrenocortical cell line: a metabolomics approach Chem. Res. Toxicol. 25 2012 1720 1731
53. M. Reitsma, T.F.H. Bovee, A.A.C.M. Peijnenburg, P.J. Hendriksen, L.A.P. Hoogenboom, and J.C.W. Rijk Endocrine disrupting effects of thioxanthone photoinitiators Toxicol. Sci. 132 2013 64 74
54. S. Wang, J.C. Rijk, H.T. Besselink, R. Houtman, A.A. Peijnenburg, A. Brouwer, I.M. Rietjens, and T.F. Bovee Extending an in vitro panel for estrogenicity testing: the added value of bioassays for measuring antiandrogenic activities and effects on steroidogenesis Toxicol. Sci. 2014 10.1093/toxsci/kfu103
55. OECD, Test No. 456: H295R steroidogenesis assay, OECD Guidelines for the Testing of Chemicals. Available at: http://www.oecd-ilibrary.org/environment/test-no-456-h295r-steroidogenesis-assay-9789264122642-en.
56. S.R. Bornstein Predisposing factors for adrenal insufficiency N. Engl. J. Med. 360 2009 2328 2339
57. T. Hakki, and R. Bernhardt CYP17- and CYP11B-dependent steroid hydroxylases as drug development targets Pharmacol. Ther. 111 2006 27 52
58. R.I.G. Holt, and N.A. Hanley An overview of human adrenal dysfunction P.W. Harvey, D.J. Everett, C.J. Springall, Adrenal Toxicology 2009 Informa Healthcare New York 39 75
59. P.W. Harvey, and D.J. Everett Regulation of endocrine-disrupting chemicals: critical overview and deficiencies in toxicology and risk assessment for human health Best Pract. Res. Clin. Endocrinol. Metab. 20 2006 145 165